Search All News
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Chronic liver disease is surging in the United States. No group is more affected than Asian Americans and Pacific Islanders (AAPI).
- March 11, 2020
Researchers across Columbia University—including psychiatrists, data scientists, social workers, and engineers—are combining their efforts to address the opioid and substance use crisis.
- March 11, 2020
About 13% of pregnant women who are depressed use cannabis, while only 4% of pregnant women without depression do, according to a new study from Columbia University Mailman School of Public Health.
- March 5, 2020
The National Institutes of Health has provided the Center for Infection and Immunity live SARS-CoV-2 samples to use in research to develop rapid tests and identify sources of transmission.
- February 21, 2020
Three CUIMC students have already put their naloxone training into action and saved the lives of strangers who had overdosed on opioids.
- February 3, 2020
Cities with strong rail networks, including Barcelona, have the lowest road injury rates, while U.S. cities still experience high road injury rates from city designs that encourage motor vehicle use.
- January 9, 2020
Researchers hoped treatment of HIV-infected infants within hours of birth would increase remission, but a new study finds that starting treatment within the first two weeks leads to similar outcomes.
- December 10, 2019
Moms are subjected to more scrutiny, but binge drinking has increased in nearly all groups of adults in the past decade, a new study from the Mailman School of Public Health has found.
- November 20, 2019
Among adults, frequent use of marijuana rose by 23% and cannabis use disorder increased by 37% in Colorado, Washington, Alaska, and Oregon, the first states to legalize marijuana for recreational use.
- November 13, 2019
How to provide high-quality care—and pay for it—remains a critical public health debate. Three Mailman policy experts discuss the feasibility of single-payer and other options.